Metraipolis › archive › dc_e9ecdd466292

Baseline predictors of visual response and treatment burden after ranibizumab therapy in macular edema secondary to retinal vein occlusion — Europe PMC PMID:42359082

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42359082
DOI
10.3389/fmed.2026.1856268
License (as archived)
solo-consultazione
Archived
2026-10-31T14:41:58.370Z
SHA-256 of the archived text
8156c8e504ced60ac1b41fdd2233ba091fc586a264609c07d09f737ab2dfffce
Stable URL of this page
https://metraipolis.com/documento/dc_e9ecdd466292

How to cite

Baseline predictors of visual response and treatment burden after ranibizumab therapy in macular edema secondary to retinal vein occlusion — Europe PMC PMID:42359082 — Europe PMC (en), https://europepmc.org/article/MED/42359082 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e9ecdd466292 (Metraipolis archive dc_e9ecdd466292, sha256 8156c8e504ced60ac1b41fdd2233ba091fc586a264609c07d09f737ab2dfffce)
BibTeX
@misc{dce9ecdd466292,
  title = {Baseline predictors of visual response and treatment burden after ranibizumab therapy in macular edema secondary to retinal vein occlusion — Europe PMC PMID:42359082},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42359082},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e9ecdd466292; sha256 8156c8e504ced60ac1b41fdd2233ba091fc586a264609c07d09f737ab2dfffce},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42359082. Agents can read the archived copy with the MCP tool read_document.